Literature DB >> 16202394

Failure to confirm allelic association between markers at the CAPON gene locus and schizophrenia in a British sample.

Vinay Puri1, Andrew McQuillin, Srinivasa Thirumalai, Jacob Lawrence, Robert Krasucki, Khalid Choudhury, Susmita Datta, Simon Kerwin, Digby Quested, Nicholas Bass, Jonathan Pimm, Graham Lamb, Helen Moorey, Gomathinayagam Kandasami, Allison Badacsonyi, Katie Kelly, Jenny Morgan, Bhaskar Punukollu, Haitham Nadeem, David Curtis, Hugh M D Gurling.   

Abstract

BACKGROUND: Linkage studies have confirmed that chromosome 1q23.3 is a susceptibility locus for schizophrenia. It was then claimed that markers at the carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase (CAPON) gene showed allelic association with schizophrenia in Canadian families. A second Chinese study found a base pair polymorphism at the CAPON gene also associated with schizophrenia.
METHODS: We attempted replication using eight markers from the Canadian study in a UK based sample of 450 cases and 450 supernormal controls.
RESULTS: We found no evidence for allelic or haplotypic association with schizophrenia for any of the markers found to be associated in the Canadian sample.
CONCLUSIONS: The negative results might reflect genetic heterogeneity between the Canadian, Chinese and UK samples or be due to methodological problems. The present finding weakens the evidence that mutations or variation in the CAPON gene are causing genetic susceptibility to schizophrenia in European populations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16202394     DOI: 10.1016/j.biopsych.2005.08.015

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  11 in total

1.  NOS1AP in schizophrenia.

Authors:  Linda M Brzustowicz
Journal:  Curr Psychiatry Rep       Date:  2008-04       Impact factor: 5.285

2.  A genetic association study of chromosome 11q22-24 in two different samples implicates the FXYD6 gene, encoding phosphohippolin, in susceptibility to schizophrenia.

Authors:  Khalid Choudhury; Andrew McQuillin; Vinay Puri; Jonathan Pimm; Susmita Datta; Srinivasa Thirumalai; Robert Krasucki; Jacob Lawrence; Nicholas J Bass; Digby Quested; Caroline Crombie; Gillian Fraser; Nicholas Walker; Haitham Nadeem; Sophie Johnson; David Curtis; David St Clair; Hugh M D Gurling
Journal:  Am J Hum Genet       Date:  2007-03-01       Impact factor: 11.025

Review 3.  Possible mechanisms of neurodegeneration in schizophrenia.

Authors:  Iván Pérez-Neri; Jesús Ramírez-Bermúdez; Sergio Montes; Camilo Ríos
Journal:  Neurochem Res       Date:  2006-09-28       Impact factor: 3.996

4.  Nitric oxide synthase 1 adaptor protein, a protein implicated in schizophrenia, controls radial migration of cortical neurons.

Authors:  Damien Carrel; Kristina Hernandez; Munjin Kwon; Christine Mau; Meera P Trivedi; Linda M Brzustowicz; Bonnie L Firestein
Journal:  Biol Psychiatry       Date:  2014-10-30       Impact factor: 13.382

5.  Evidence for a role of the NOS1AP (CAPON) gene in schizophrenia and its clinical dimensions: an association study in a South American population isolate.

Authors:  Barbara Kremeyer; Jenny García; Hanna Kymäläinen; Naomi Wratten; Gabriel Restrepo; Carlos Palacio; Ana Lucía Miranda; Carlos López; Margarita Restrepo; Gabriel Bedoya; Linda M Brzustowicz; Jorge Ospina-Duque; María Patricia Arbeláez; Andrés Ruiz-Linares
Journal:  Hum Hered       Date:  2008-12-15       Impact factor: 0.444

6.  Mutation screening of NOS1AP gene in a large sample of psychiatric patients and controls.

Authors:  Richard Delorme; Catalina Betancur; Isabelle Scheid; Henrik Anckarsäter; Pauline Chaste; Stéphane Jamain; Franck Schuroff; Gudrun Nygren; Evelyn Herbrecht; Anne Dumaine; Marie Christine Mouren; Maria Råstam; Marion Leboyer; Christopher Gillberg; Thomas Bourgeron
Journal:  BMC Med Genet       Date:  2010-07-05       Impact factor: 2.103

Review 7.  Which perspectives can endophenotypes and biological markers offer in the early recognition of schizophrenia?

Authors:  S Bender; M Weisbrod; F Resch
Journal:  J Neural Transm (Vienna)       Date:  2007-05-21       Impact factor: 3.575

8.  Association of RGS2 and RGS5 variants with schizophrenia symptom severity.

Authors:  Daniel B Campbell; Leslie A Lange; Tara Skelly; Jeffrey Lieberman; Pat Levitt; Patrick F Sullivan
Journal:  Schizophr Res       Date:  2008-02-11       Impact factor: 4.939

Review 9.  Role of nitric oxide and related molecules in schizophrenia pathogenesis: biochemical, genetic and clinical aspects.

Authors:  Regina F Nasyrova; Dmitriy V Ivashchenko; Mikhail V Ivanov; Nikolay G Neznanov
Journal:  Front Physiol       Date:  2015-05-11       Impact factor: 4.566

10.  Failure to confirm allelic and haplotypic association between markers at the chromosome 6p22.3 dystrobrevin-binding protein 1 (DTNBP1) locus and schizophrenia.

Authors:  Susmita R Datta; Andrew McQuillin; Vinay Puri; Khalid Choudhury; Srinivasa Thirumalai; Jacob Lawrence; Jonathan Pimm; Nicholas Bass; Graham Lamb; Helen Moorey; Jenny Morgan; Bhaskar Punukollu; Gomathinayagam Kandasami; Simon Kirwin; Akeem Sule; Digby Quested; David Curtis; Hugh Md Gurling
Journal:  Behav Brain Funct       Date:  2007-09-23       Impact factor: 3.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.